Business
Mesoblast share price on the rise after delivering promising FY20 results – Motley Fool Australia
The Mesoblast share price is on the rise this morning after the company delivered positive FY20 results and sets itself up for FY21.
The share price of ASX junior biotechnology company Mesoblast Limited (ASX:MSB) is on the move after the company released its FY20 results to the market Thursday morning. At the time of writing, the Mesoblast share price had risen 3.69% to $5.34.
What’s moving the Mesoblast share price?
The Mesoblast share price has been boosted after the company reported a 92% increase in revenues to US$32.2 million, while its loss after tax decreased by 13% year on year to US$77.9 million. Despite posting a …
-
Noosa News20 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General21 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General15 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General14 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues